Education
About Us
Working with TipRanks
Follow Us
Masimo Corp. (MASI)
NASDAQ:MASI
MASI Stock Chart & Stats
$175.35
$0.33(0.20%)
At close: 4:00 PM EST
$175.35
$0.33(0.20%)
Day’s Range― - ―
52-Week Range$125.94 - $194.88
Previous CloseN/A
Volume102.94K
Average Volume (3M)1.71M
Market Cap
$13.02B
Enterprise Value$9.83B
Total Cash (Recent Filing)$152.30M
Total Debt (Recent Filing)$518.00M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
May 12, 2026EPS Estimate
1.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.18
Shares Outstanding74,218,780
10 Day Avg. Volume3,751,969
30 Day Avg. Volume1,710,324
Financial Highlights & Ratios
PEG Ratio0.89
Price to Book (P/B)9.47
Price to Sales (P/S)4.47
P/FCF Ratio34.52
Enterprise Value/Market Cap0.75
Enterprise Value/Revenue6.44
Enterprise Value/Gross Profit10.40
Enterprise Value/Ebitda27.07
Forecast
1Y Price Target
$180.00Price Target Upside2.65% Upside
Rating ConsensusHold
Number of Analyst Covering6
EPS Forecast (FY)5.9
Revenue Forecast (FY)$1.63B
Bulls Say, Bears Say
Bulls Say
Acquisition Premium And Strategic FitDanaher's agreed acquisition of Masimo provides a sizeable premium to shareholders and pairs Masimo's technology with Danaher's diagnostics scale, which could accelerate global commercialization of key products.
Demand Strength And Improved Long-term TargetsBeating revenue and shipment expectations, record incremental contract value, and long-term guidance for 2026–2028 above consensus support the outlook for accelerating revenue growth and margin expansion.
Product Differentiation And Clinical InnovationNew pulse oximetry sensors and algorithm-driven features that detect opioid-related respiratory depression and atrial fibrillation create differentiated clinical capabilities that can drive adoption versus competitors.
Bears Say
Analyst Coverage DisruptionChange to No Rating and removal of the price objective indicate analysts view the stock as no longer trading on company fundamentals, reducing actionable coverage for investors.
Limited Upside For Public SharesAcquisition price aligned with prior analyst targets has led to downgrades and suggests little remaining upside for the public stock, lowering incentive for continued public ownership.
Reduced Near-term TransparencyCancellation of the scheduled earnings call and analysts waiting for full-quarter results and next-year guidance cut near-term public updates and increase short-term uncertainty for investors.
Masimo News
MASI FAQ
What was Masimo Corp.’s price range in the past 12 months?
Masimo Corp. lowest stock price was $125.94 and its highest was $194.88 in the past 12 months.
What is Masimo Corp.’s market cap?
Masimo Corp.’s market cap is $13.02B.
When is Masimo Corp.’s upcoming earnings report date?
Masimo Corp.’s upcoming earnings report date is May 12, 2026 which is in 69 days.
How were Masimo Corp.’s earnings last quarter?
Masimo Corp. released its earnings results on Feb 26, 2026. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of $1.479 by -$1.659.
Is Masimo Corp. overvalued?
According to Wall Street analysts Masimo Corp.’s price is currently Undervalued.
Does Masimo Corp. pay dividends?
Masimo Corp. pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on Masimo Corp. dividends here
What is Masimo Corp.’s EPS estimate?
Masimo Corp.’s EPS estimate is 1.43.
How many shares outstanding does Masimo Corp. have?
Masimo Corp. has 74,218,780 shares outstanding.
What happened to Masimo Corp.’s price movement after its last earnings report?
Masimo Corp. reported an EPS of -$0.18 in its last earnings report, missing expectations of $1.479. Following the earnings report the stock price went up 0.074%.
Which hedge fund is a major shareholder of Masimo Corp.?
Currently, no hedge funds are holding shares in MASI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Masimo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$180.00 (2.65% Upside)
$180.00 (2.65% Upside)
Blogger Sentiment
Bullish
MASI Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 616.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 7.2%
Last 30 Days ▲ 7.2%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-5.82%
12-Months-Change
Fundamentals
Return on Equity
23.43%
Trailing 12-Months
Asset Growth
-35.30%
Trailing 12-Months
Company Description
Masimo Corp.
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
MASI Company Deck
MASI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Masimo delivered strong financial performance with significant revenue growth, operating margin expansion, and increased EPS. Strategic partnerships and shareholder returns were also notable achievements. However, challenges such as a decline in gross margin due to tariffs, and lower-than-expected consumables growth, along with tightened revenue guidance, presented some concerns.View all MASI earnings summariesMASI Stock 12 Month Forecast
Average Price Target
$180.00
▲(2.65% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---